Gene · 220
Papers1,919
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,919
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| LHPP Inhibits the Viability, Migration, and Proliferation of PDAC Cells and Significantly Affects the Expression of SDC1 and S100p. | Technol Cancer Res Treat | 2023 | 37321804 | PubTator, text mining | PubMed |
| The Molecular Context of Oxidant Stress Response in Cancer Establishes ALDH1A1 as a Critical Target: What This Means for Acute Myeloid Leukemia. | Int J Mol Sci | 2023 | 37298333 | PubTator, text mining | PubMed |
| Molecular Biology of Pediatric and Adult Ovarian Germ Cell Tumors: A Review. | Cancers (Basel) | 2023 | 37296950 | PubTator, text mining | PubMed |
| Engineered extracellular matrices facilitate brain organoids from human pluripotent stem cells. | Ann Clin Transl Neurol | 2023 | 37283238 | PubTator, text mining | PubMed |
| High expression of PKCλ and ALDH1A3 indicates a poor prognosis, and PKCλ is required for the asymmetric cell division of ALDH1A3-positive cancer stem cells in PDAC. | Biochem Biophys Res Commun | 2023 | 37267864 | PubTator, text mining | PubMed |
| Aldehyde Dehydrogenase, a Marker of Normal and Malignant Stem Cells, Typifies Mesenchymal Progenitors in Perivascular Niches. | Stem Cells Transl Med | 2023 | 37261440 | PubTator, text mining | PubMed |
| Targeting breast cancer stem cells directly to treat refractory breast cancer. | Front Oncol | 2023 | 37251931 | PubTator, text mining | PubMed |
| Exploring the Molecular Players behind the Potentiation of Chemotherapy Effects by Durvalumab in Lung Adenocarcinoma Cell Lines. | Pharmaceutics | 2023 | 37242727 | PubTator, text mining | PubMed |
| Effects of Vitamin A on Immune Responses and Vitamin A Metabolism in Broiler Chickens Challenged with Necrotic Enteritis. | Life (Basel) | 2023 | 37240767 | PubTator, text mining | PubMed |
| Regulation of Cancer Stem Cells and Epithelial-Mesenchymal Transition by CTNNAL1 in Lung Cancer and Glioblastoma. | Biomedicines | 2023 | 37239133 | PubTator, text mining | PubMed |
| FOXD1 is associated with poor outcome and maintains tumor-promoting enhancer-gene programs in basal-like breast cancer. | Front Oncol | 2023 | 37234983 | PubTator, text mining | PubMed |
| AhR and Wnt/β-Catenin Signaling Pathways and Their Interplay. | Curr Issues Mol Biol | 2023 | 37232717 | PubTator, text mining | PubMed |
| A survey of experts on personalized medicine landscape in European Union and China. | BMC Health Serv Res | 2023 | 37221524 | PubTator, text mining | PubMed |
| A prediction model identifying glycolysis signature as therapeutic target for psoriasis. | Front Immunol | 2023 | 37205116 | PubTator, text mining | PubMed |
| Cytosolic Enzymes Generate Cannabinoid Metabolites 7-Carboxycannabidiol and 11-Nor-9-carboxytetrahydrocannabinol. | ACS Med Chem Lett | 2023 | 37197460 | PubTator, text mining | PubMed |
| Zebrafish as a Model to Study Retinoic Acid Signaling in Development and Disease. | Biomedicines | 2023 | 37189798 | PubTator, text mining | PubMed |
| IL-3 produced by T cells is crucial for basophil extravasation in hapten-induced allergic contact dermatitis. | Front Immunol | 2023 | 37180157 | PubTator, text mining | PubMed |
| Breaking the Mold: Epigenetics and Genomics Approaches Addressing Novel Treatments and Chemoresponse in TGCT Patients. | Int J Mol Sci | 2023 | 37175579 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Sarcomas: In Vitro Isolation and Role as Prognostic Markers: A Systematic Review. | Cancers (Basel) | 2023 | 37173919 | PubTator, text mining | PubMed |
| Sexual dimorphism in obesity is governed by RELMα regulation of adipose macrophages and eosinophils. | Elife | 2023 | 37162190 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/220/papers?page=13